{
    "title": "India says safety concerns restricting use of Merck COVID pill",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10371575/India-says-safety-concerns-restricting-use-Merck-COVID-pill.html",
    "date": "2022-01-05",
    "keywords": [
        "drug",
        "pill",
        "health",
        "merck",
        "treatment",
        "safety",
        "week",
        "birth",
        "market",
        "uk",
        "november",
        "delhi",
        "jan",
        "protocol",
        "disease",
        "use",
        "official",
        "wednesday",
        "head",
        "staterun",
        "council",
        "research",
        "teratogenicity",
        "mutagenicity",
        "cartilage",
        "damage",
        "contraception",
        "child",
        "development",
        "foetus",
        "material",
        "person",
        "drugmaker",
        "dr",
        "reddys",
        "version",
        "comment",
        "class",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalshowdoesmerckscovid19pillcomparepfizers20211105",
        "cancer",
        "bhargava",
        "countrys",
        "month",
        "sale",
        "recommendation",
        "part",
        "taskforce",
        "committee",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalsusfdapanelweighmerckscovid19antiviraldrug20211130",
        "virus",
        "defect",
        "pregnancy",
        "country",
        "reporting",
        "krishna",
        "n",
        "das",
        "banerjee",
        "editing",
        "andrew",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}